Tumor-targeting oncolytic virus elicits potent immunotherapeutic vaccine responses to tumor antigens

Oncolytic viruses represent a promising therapeutic modality, but they have yet to live up to their therapeutic potential. Safety and efficacy concerns impel us to identify least toxic oncolytic agents that would generate durable and multifaceted anti-tumor immune responses to disrupt the tumors. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yong, Lin, Chaolong, Zou, Yidi, Ju, Fei, Ren, Wenfeng, Lin, Yanhua, Wang, Yale, Huang, Xiaoxuan, Liu, Huiling, Yu, Zeng, Liu, Pingguo, Tan, Guowei, Yuan, Quan, Zhang, Jun, Huang, Chenghao, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028326/
https://www.ncbi.nlm.nih.gov/pubmed/32117591
http://dx.doi.org/10.1080/2162402X.2020.1726168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028326/
https://www.ncbi.nlm.nih.gov/pubmed/32117591
http://dx.doi.org/10.1080/2162402X.2020.1726168

Ejemplares similares